secwatch.observer — SEC 8-K summary
======================================

Issuer:     Edwards Lifesciences Corp (EW)
CIK:        0001099800
Form:       8-K
Filed at:   2023-02-21T23:59:59+00:00
Accession:  0001193125-23-043538
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Edwards Lifesciences amends bylaws to adopt universal proxy rules and update advance notice provisions
--------------------------------------------------------------------------------

- Bylaws amended to incorporate Rule 14a-19 universal proxy requirements for director nominations.
- Stockholders must provide evidence of compliance with universal proxy rules, including soliciting at least 67% voting power.
- Advance notice provisions updated with additional disclosure requirements for nominees and proposing stockholders.
- Company may require proposed nominees to submit to interviews with the Board or a committee.
- Other technical and conforming changes to align with recent amendments to Delaware General Corporation Law.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1099800/000119312523043538/0001193125-23-043538-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1099800/000119312523043538/d452156d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-043538

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer